[New drugs for small animals in 2024]

In 2024, three novel pharmaceutical agents for small animals were released on the German veterinary medicinal products market: the histamine H₂-receptor antagonist ranitidine for the treatment of gastric ulcers, the alpha-2-adrenoceptor agonist tasipimidine for the relief of anxiety and the SGLT-2 inhibitor velagliflozin for the insulin-independent treatment of diabetes mellitus. No active substance was extended to other animal species. The following are new to the market for small animals: two active substances (amlodipine; fluralaner), each in a new dosage form, a new combination of active substances (neomycin sulphate + polymyxin B sulphate) and one active substance (trilostane) in two new dosage forms. There were no vaccines for small animals against new diseases and no new dosage forms. A new recombinant vaccine against Rabbit Hemorrhagic Disease Virus was approved.